Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Significance: AntagomiR-based anti-hypertensive therapy: Anti-miR-29 suppresses angiotensin II-induced vascular remodelling and hypertension via up regulation of its target gene. Thus, pharmacological formulations encompassing “Anti-miR-29 or inhibitors of miR-29” may be used to decrease blood pressure.
Amount: $ 500
Undisclosed information: How Anti-miR-29 suppresses angiotensin II-induced vascular remodelling and hypertension
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, AntagomiR-based anti-hypertensive therapy: Anti-miR-29 suppresses angiotensin II-induced vascular remodelling and hypertension via up regulation of its target gene, 21/January/2014, 12.09 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation